Company Filing History:
Years Active: 1978
Title: Waldemar Bluethgen: Innovator in Bioactive Composite Materials
Introduction
Waldemar Bluethgen is a notable inventor based in Munich, Germany. He has made significant contributions to the field of bioactive composite materials, particularly in the context of prosthetic applications. His innovative work has led to the development of a unique composite material that has practical uses in surgery and orthopedics.
Latest Patents
Waldemar Bluethgen holds a patent for a bioactive composite material process of producing and method of using. This composite material is primarily composed of a plastic matrix, preferably of a methacrylate plastic, and at least one bioactive filler material, which is ideally a glass ceramic material of apatite crystal structure. The finely comminuted bioactive material can be incorporated homogeneously or nonhomogeneously into the plastic matrix. Additionally, reinforcing additives such as glass fibers may be included to enhance the mechanical strength properties. This innovative composite material is particularly useful as bone cement or tooth replacement material, making it a valuable asset in the field of prosthetics.
Career Highlights
Waldemar Bluethgen has had a distinguished career, working at Ernst Leitz GmbH, where he has been able to apply his expertise in material science. His work has not only advanced the field of prosthetics but has also contributed to the overall understanding of bioactive materials in medical applications.
Collaborations
Throughout his career, Waldemar has collaborated with notable colleagues, including Heinz Broemer and Klaus K Deutscher. These collaborations have further enriched his research and development efforts, leading to innovative solutions in the field of bioactive materials.
Conclusion
Waldemar Bluethgen's contributions to the development of bioactive composite materials have made a significant impact in the field of prosthetics. His innovative patent and collaborative efforts highlight his dedication to advancing medical technology.